Login / Signup

Combinations of single nucleotide polymorphisms WWOX-rs13338697, GALNT14-rs9679162 and rs6025211 effectively stratify outcomes of chemotherapy in advanced hepatocellular carcinoma.

Wey-Ran LinChao-Wei HsuChristopher Sung-Huan YehYi-Cheng ChenMing-Ling ChangKung-Hao LiangChen-Chun LinYu-De ChuChau-Ting Yeh
Published in: Asia-Pacific journal of clinical oncology (2017)
Three genetic variants, GALNT14-rs9679162, WWOX-rs13338697 and rs6025211, stratified advanced HCC patients into three groups with differential treatment outcomes.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • radiation therapy
  • skeletal muscle
  • rectal cancer
  • patient reported